Skip to main content
SpringerLink
Log in

Hypertension in the Young Adult

  • Chapter
Endocrinology and Diabetes

  • 1913 Accesses

Abstract

Hypertension is the most common cardiovascular condition to be seen in primary care. It also represents the strongest single modifiable risk factor with regards to future morbidity and mortality. The incidence of hypertension is predicted to continue to increase, being contributed to by an ageing population.

The major consequence of this largely asymptomatic condition is the development of cardiovascular sequelae. The aim of early diagnosis is to provide an opportunity to intervene in order to prevent or delay the onset of overt vascular disease. The positive effects of treatment have been proven in numerous randomised placebo-controlled trials. However since hypertension is usually asymptomatic and treatment is aimed at prevention of complications, targeting patients at highest risk while avoiding ‘medicalisation’ and causing side effects in people at low risk is challenging. This is especially the case in young people for whom a diagnosis of hypertension entails life-long treatment, based upon studies performed in older people. Using a clinical example we will review some of those challenges and how to deal with them in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of death. Lancet. 2002;360(9343):1347–60.

    Article  PubMed  Google Scholar 

  2. Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of “normal”. J Gen Intern Med. 2011;26:685.

    Article  PubMed Central  PubMed  Google Scholar 

  3. National Statistics. Health Service for England 2010—trend tables. NHS Information Centre. 2011. Available at http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/health-survey-for-england/health-survey-for-england-2010-trend-tables. Accessed 1 Dec 2013.

  4. Tu K, Chen Z, Lipscombe LL, for the Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008;178(11):1429–35.

    Google Scholar 

  5. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23(11):1170–8.

    Article  CAS  PubMed  Google Scholar 

  6. Williams B. Hypertension and “J-curve”. J Am Coll Cardiol. 2009;54:1835–6.

    Article  PubMed  Google Scholar 

  7. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.

    Article  PubMed  Google Scholar 

  8. National Clinical Guideline Centre (NCGC). Hypertension: the clinical management of primary hypertension in adults., Clinical guideline 127. Methods, evidence and recommendations. Commissioned by the National Institute for Health and Clinical Excellence. London: NCGC; 2011.

    Google Scholar 

  9. Tirosh A, Afek A, Rudich A, Percik R, Gordon B, Ayalon N, et al. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010;56:203–9.

    Article  CAS  PubMed  Google Scholar 

  10. Nguyen QC, Tabor JW, Entzel PP, Lau Y, Suchindran C, Hussey J, et al. Discordance in national estimates of hypertension among young adults. Epidemiology. 2011;22(4):532–41.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Gaziano TA, Bitton A, Anand S, Weinstein MC, International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472–7.

    Article  CAS  PubMed  Google Scholar 

  12. Greenland P, Knoll MD, Stamler J, Naeton JD, Dyer AR, Garsdie DB, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891.

    Article  PubMed  Google Scholar 

  13. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112.

    Article  CAS  PubMed  Google Scholar 

  14. Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens. 2012;30:842.

    Article  CAS  PubMed  Google Scholar 

  15. Yan LL, Liu K, Matthews KA, Daviglus ML, Freeman T, Kiefe C. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA. 2003;290:2138.

    Article  CAS  PubMed  Google Scholar 

  16. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29:636.

    Article  CAS  PubMed  Google Scholar 

  17. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(1903):1913. Erratum in Lancet 2003 Mar 22;361(9362):1060.

    Google Scholar 

  18. Chrysant SG. Current status of aggressive blood pressure control. World J Cardiol. 2011;3(3):65–71.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.

    Article  PubMed  Google Scholar 

  20. Moreno G, Mangione CM. Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002–2012 literature review. J Am Geriatr Soc. 2013;61(11):2027–37.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159:185.

    Article  PubMed  Google Scholar 

  22. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24:779.

    Article  CAS  PubMed  Google Scholar 

  23. O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697.

    Article  PubMed  Google Scholar 

  24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560.

    Article  CAS  PubMed  Google Scholar 

  25. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.

    Article  CAS  PubMed  Google Scholar 

  26. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898.

    Article  PubMed  Google Scholar 

  27. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011;40(2):295–311.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. Br Med J (Clin Res Ed). 1986;292:235.

    Article  CAS  Google Scholar 

  29. Shantsila A, Shantsila E, Lip GY. Malignant hypertension: a rare problem or is it underdiagnosed? Curr Vasc Pharmacol. 2010;8(6):775–9.

    Article  CAS  PubMed  Google Scholar 

  30. Severe symptomless hypertension. Lancet. 1989;9(2):1369–70.

    Google Scholar 

  31. Yoon EY, Cohn L, Freed G, Rocchini A, Kershaw D, Ascione F, et al. Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension. J Adolesc Health. 2014; pii:S1054-139X(13)00800-8.

    Google Scholar 

  32. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2013. doi:10.1093/eurheartj/eht534.

    Google Scholar 

  33. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193–202.

    Article  PubMed  Google Scholar 

  34. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493.

    Article  CAS  PubMed  Google Scholar 

  35. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.

    Article  CAS  PubMed  Google Scholar 

  36. Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42(2):161–5.

    Article  CAS  PubMed  Google Scholar 

  37. Novick AC, Zaki S, Goldfarb D, Hodge EE. Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients. J Vasc Surg. 1994;20:1.

    Article  CAS  PubMed  Google Scholar 

  38. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362–74.

    Article  PubMed  Google Scholar 

  39. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 2010;23:1159.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Betensky BP, Jaeger JR, Woo EY. Unequal blood pressures: a manifestation of subclavian steal. Am J Med. 2011;124:e1.

    Article  PubMed  Google Scholar 

  41. Streeten DH, Anderson Jr GH, Howland T, Chiang R, Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension. 1988;11:78.

    Article  CAS  PubMed  Google Scholar 

  42. Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, et al. Relation between serum calcium, phosphate, parathyroid hormone and ‘nondipper’ circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 2007;27:516.

    Article  CAS  PubMed  Google Scholar 

  43. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, et al. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem. 2005;51:735–44.

    Article  CAS  PubMed  Google Scholar 

  44. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52:686.

    Article  PubMed  Google Scholar 

  45. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing’s syndrome. J Clin Endocrinol Metab. 1986;62:275.

    Article  CAS  PubMed  Google Scholar 

  46. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf). 2004;61:768.

    Article  Google Scholar 

  47. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144:485.

    Article  PubMed  Google Scholar 

  48. Carnethon MR, Evans NS, Church TS, Lewis CE, Schreiner PJ, Jacobs Jr DR. Joint associations of physical activity and aerobic fitness on the development of incident hypertension: coronary artery risk development in young adults. Hypertension. 2010;56:49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al.; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3–10.

    Google Scholar 

  50. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302:401.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166(2):357–64.

    Article  CAS  PubMed  Google Scholar 

  52. Blood Pressure Lowering Treatment Trialists’ Collaboration, Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:112.

    Article  Google Scholar 

  53. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510.

    Article  PubMed  Google Scholar 

  54. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, et al. Effects of dietary sodium restriction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:444–6.

    Article  Google Scholar 

  55. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203.

    Article  CAS  PubMed  Google Scholar 

  56. Faselis C, Doumas M, Papademetriou V. Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens. 2011;2011:236239.

    PubMed Central  PubMed  Google Scholar 

  57. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006;48:833.

    Article  PubMed  Google Scholar 

  58. Asayama K, Ohkubo T, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke. 2004;35:2356.

    Article  PubMed  Google Scholar 

  59. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911–7.

    Article  Google Scholar 

  60. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.

    Article  Google Scholar 

  61. Medtronic announces US renal denervation pivotal trial fails to meet primary efficacy endpoint while meeting primary safety end point [press release]. 9 Jan 2014.

    Google Scholar 

  62. Sapoval M; Assistance Publique – Hôpitaux de Paris. Renal Denervation in Hypertension (DENER-HTN). In: ClinicalTrials.gov[Internet]. Bethesda: National Library of Medicine (US). 2000-[cited 22 Feb 2014]. Available from: http://clinicaltrials.gov/show/NCT01570777; NLM Identifier NCT01570777.

  63. Schlaich M, Baker IDI Heart and Diabetes Institute. Renal Denervation for Resistant Hypertension (RDNP-2012-01). In: ClinicalTrials.gov[Internet]. Bethesda: National Library of Medicine (US). 2000-[cited 10 Mar 2014]. Available from: http://clinicaltrials.gov/show/NCT01865240; NLM Identifier NCT01865240

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular and Diabetes Research, University of Leeds, LIGHT laboratories, Clarendon Way, Leeds, LS16 5AR, UK

    Klaus K. Witte MD, FRCP & Haqeel A. Jamil MBChB, MRCP

Authors
  1. Klaus K. Witte MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haqeel A. Jamil MBChB, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus K. Witte MD, FRCP .

Editor information

Editors and Affiliations

  1. Cardiovascular and Diabetes Research, University of Leeds, Leeds, United Kingdom

    Ramzi Ajjan

  2. Department of Endocrinology, St. James’s Hospital, Leeds, United Kingdom

    Stephen M. Orme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Witte, K.K., Jamil, H.A. (2015). Hypertension in the Young Adult. In: Ajjan, R., Orme, S. (eds) Endocrinology and Diabetes. Springer, London. https://doi.org/10.1007/978-1-4471-2789-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2789-5_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2788-8

  • Online ISBN: 978-1-4471-2789-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation